Cargando…

M015 A PATIENT WITH AN ALLERGIC REACTION TO THE PFIZER COVID-19 VACCINE SUBSEQUENTLY TOLERATES JOHNSON&JOHNSON VACCINATION

Detalles Bibliográficos
Autores principales: Patterson, A., Ren, Z., Jerath, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566852/
http://dx.doi.org/10.1016/j.anai.2021.08.189
_version_ 1784594105946341376
author Patterson, A.
Ren, Z.
Jerath, M.
author_facet Patterson, A.
Ren, Z.
Jerath, M.
author_sort Patterson, A.
collection PubMed
description
format Online
Article
Text
id pubmed-8566852
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-85668522021-11-04 M015 A PATIENT WITH AN ALLERGIC REACTION TO THE PFIZER COVID-19 VACCINE SUBSEQUENTLY TOLERATES JOHNSON&JOHNSON VACCINATION Patterson, A. Ren, Z. Jerath, M. Ann Allergy Asthma Immunol Article Published by Elsevier Inc. 2021-11 2021-11-04 /pmc/articles/PMC8566852/ http://dx.doi.org/10.1016/j.anai.2021.08.189 Text en Copyright © 2021 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Patterson, A.
Ren, Z.
Jerath, M.
M015 A PATIENT WITH AN ALLERGIC REACTION TO THE PFIZER COVID-19 VACCINE SUBSEQUENTLY TOLERATES JOHNSON&JOHNSON VACCINATION
title M015 A PATIENT WITH AN ALLERGIC REACTION TO THE PFIZER COVID-19 VACCINE SUBSEQUENTLY TOLERATES JOHNSON&JOHNSON VACCINATION
title_full M015 A PATIENT WITH AN ALLERGIC REACTION TO THE PFIZER COVID-19 VACCINE SUBSEQUENTLY TOLERATES JOHNSON&JOHNSON VACCINATION
title_fullStr M015 A PATIENT WITH AN ALLERGIC REACTION TO THE PFIZER COVID-19 VACCINE SUBSEQUENTLY TOLERATES JOHNSON&JOHNSON VACCINATION
title_full_unstemmed M015 A PATIENT WITH AN ALLERGIC REACTION TO THE PFIZER COVID-19 VACCINE SUBSEQUENTLY TOLERATES JOHNSON&JOHNSON VACCINATION
title_short M015 A PATIENT WITH AN ALLERGIC REACTION TO THE PFIZER COVID-19 VACCINE SUBSEQUENTLY TOLERATES JOHNSON&JOHNSON VACCINATION
title_sort m015 a patient with an allergic reaction to the pfizer covid-19 vaccine subsequently tolerates johnson&johnson vaccination
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566852/
http://dx.doi.org/10.1016/j.anai.2021.08.189
work_keys_str_mv AT pattersona m015apatientwithanallergicreactiontothepfizercovid19vaccinesubsequentlytoleratesjohnsonjohnsonvaccination
AT renz m015apatientwithanallergicreactiontothepfizercovid19vaccinesubsequentlytoleratesjohnsonjohnsonvaccination
AT jerathm m015apatientwithanallergicreactiontothepfizercovid19vaccinesubsequentlytoleratesjohnsonjohnsonvaccination